Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7126
CALL
Kaiser Aluminum
KALU
$2.64B
| $910K | ﹤0.01% |
11,500
-1,300
| -10% | -$122K |
|
|
SNBR
7127
CALL
DELISTED
Sleep Number
SNBR
| $910K | ﹤0.01% |
29,400
+4,600
| +19% | +$195K |
|
7128
PUT
California Resources
CRC
$4.72B
| $909K | ﹤0.01% |
23,600
-13,400
| -36% | -$575K |
|
7129
CALL
Cardlytics
CDLX
$24.3M
| $908K | ﹤0.01% |
4,070
-150
| -4% | -$50.2K |
|
7130
CALL
ClearPoint Neuro
CLPT
$463M
| $908K | ﹤0.01% |
69,600
+13,900
| +25% | +$142K |
|
7131
Passage Bio
PASG
$14.5M
| $908K | ﹤0.01% |
19,228
+6,868
| +56% | +$321K |
|
|
TSE
7132
CALL
DELISTED
Trinseo
TSE
| $908K | ﹤0.01% |
23,600
-3,900
| -14% | -$177K |
|
7133
Bankunited
BKU
$3.4B
| $907K | ﹤0.01% |
+25,495
| New | +$1.01M |
|
7134
CALL
Hess Midstream
HESM
$5.14B
| $907K | ﹤0.01% |
32,400
+5,500
| +20% | +$170K |
|
7135
CALL
Horizon Technology Finance
HRZN
$339M
| $907K | ﹤0.01% |
78,600
-23,700
| -23% | -$297K |
|
7136
CALL
Clover Health Investments
CLOV
$2.25B
| $906K | ﹤0.01% |
423,400
-97,500
| -19% | -$259K |
|
7137
iShares Core Universal USD Bond ETF
IUSB
$43.4B
| $906K | ﹤0.01% |
19,344
-303,049
| -94% | -$14.4M |
|
|
TCN
7138
CALL
DELISTED
Tricon Residential Inc.
TCN
| $906K | ﹤0.01% |
89,300
-74,000
| -45% | -$951K |
|
7139
CALL
International Seaways
INSW
$4.89B
| $905K | ﹤0.01% |
42,700
-8,900
| -17% | -$195K |
|
7140
PUT
KBR
KBR
$4.74B
| $905K | ﹤0.01% |
18,700
+10,400
| +125% | +$514K |
|
7141
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$358M
| $905K | ﹤0.01% |
+27,725
| New | +$1.02M |
|
|
LBAI
7142
DELISTED
Lakeland Bancorp Inc
LBAI
| $905K | ﹤0.01% |
+61,886
| New | +$949K |
|
|
DZSI
7143
DELISTED
DZS Inc. Common Stock
DZSI
| $905K | ﹤0.01% |
55,638
+13,302
| +31% | +$196K |
|
7144
CALL
Gogoro
GGR
$46.2M
| $904K | ﹤0.01% |
+5,910
| New | +$802K |
|
7145
PUT
Gildan
GIL
$10.3B
| $904K | ﹤0.01% |
31,400
+19,100
| +155% | +$611K |
|
7146
Intercorp Financial Services
IFS
$5.97B
| $904K | ﹤0.01% |
+38,613
| New | +$1.06M |
|
7147
PUT
Royalty Pharma
RPRX
$26.6B
| $904K | ﹤0.01% |
21,500
-7,200
| -25% | -$295K |
|
|
VISN
7148
CALL
Vistance Networks Inc
VISN
$2.62B
| $903K | ﹤0.01% |
147,500
-41,700
| -22% | -$291K |
|
7149
CALL
SiteOne Landscape Supply
SITE
$4.15B
| $903K | ﹤0.01% |
7,600
+1,900
| +33% | +$255K |
|
|
FOXW
7150
DELISTED
FoxWayne Enterprises Acquisition Corp. Class A Common Stock
FOXW
| $903K | ﹤0.01% |
89,115
+202
| +0.2% | +$2.04K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.